Please use this identifier to cite or link to this item:
Title: International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004-2009
Autores: Rosenthal, V. D.
International Nosocomial Infection Control Consortium members
Martínez Rodríguez de Wang, Carolina
Severino, Ramona
Tolari, Gilda
Delgado, Margarita
Researchers (UNIBE): Martínez Rodríguez de Wang, Carolina 
Severino, Ramona 
Tolari, Gilda 
Delgado, Margarita 
Affiliations: Facultad de Ciencias de la Salud 
Facultad de Ciencias de la Salud 
Facultad de Ciencias de la Salud 
Facultad de Ciencias de la Salud 
Research area: Ciencias de la Salud
Keywords: Network; Hospital infection; Nosocomial infection; Health care-associated infection; Device-associated infection; Ventilator-associated pneumonia; Catheter-associated urinary tract infection; Central line-associated bloodstream infection; Bloodstream infection; Urinary tract infection; Urinary tract infection; Antibiotic resistance; Developing countries; Limited-resources countries; Low-income countries
Issue Date: 2012
Publisher: Elsevier Inc.
Source: American Journal of Infection Control, 40, 396-407
Journal: American Journal of Infection Control 
Volume: 40
Start page: 396
End page: 407
The results of a surveillance study conducted by the International Nosocomial Infection Control Consortium (INICC) from January 2004 through December 2009 in 422 intensive care units (ICUs) of 36 countries in Latin America, Asia, Africa, and Europe are reported. During the 6-year study period, using Centers for Disease Control and Prevention (CDC) National Healthcare Safety Network (NHSN; formerly the National Nosocomial Infection Surveillance system [NNIS]) definitions for device-associated health care-associated infections, we gathered prospective data from 313,008 patients hospitalized in the consortium’s ICUs for an aggregate of 2,194,897 ICU bed-days. Despite the fact that the use of devices in the developing countries’ ICUs was remarkably similar to that reported in US ICUs in the CDC’s NHSN, rates of device-associated nosocomial infection were significantly higher in the ICUs of the INICC hospitals; the pooled rate of central line-associated bloodstream infection in the INICC ICUs of 6.8 per 1,000 central line-days was more than 3-fold higher than the 2.0 per 1,000 central line-days reported in comparable US ICUs. The overall rate of ventilator-associated pneumonia also was far higher (15.8 vs 3.3 per 1,000 ventilator-days), as was the rate of catheter-associated urinary tract infection (6.3 vs. 3.3 per 1,000 catheter-days). Notably, the frequencies of resistance of Pseudomonas aeruginosa isolates to imipenem (47.2% vs 23.0%), Klebsiella pneumoniae isolates to ceftazidime (76.3% vs 27.1%), Escherichia coli isolates to ceftazidime (66.7% vs 8.1%), Staphylococcus aureus isolates to methicillin (84.4% vs 56.8%), were also higher in the consortium’s ICUs, and the crude unadjusted excess mortalities of device-related infections ranged from 7.3% (for catheter-associated urinary tract infection) to 15.2% (for ventilatorassociated pneumonia).
DOI: 10.1016/j.ajic.2011.05.020
Appears in Collections:Publicaciones del Área de Salud - Medicina
Publicaciones indexadas en Scopus / Web of Science

Files in This Item:
File Description SizeFormat
INICC Report data summary 36 countries 2004-2009.pdfFull text [open access]202.12 kBAdobe PDFView/Open
Show full item record Recommend this item

Google ScholarTM






Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.